Clinical trials
Lung Diseases trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Pfizer | 4 |
| National Taiwan University Hospital | 3 |
| Blueprint Medicines Corporation | 2 |
| Eli Lilly and Company | 2 |
| Revolution Medicines, Inc. | 2 |
| United Therapeutics | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Ai-Ling Chang | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 36 |
| Respiratory Tract Diseases | 19 |
| Lung Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasms by Site | 10 |
| Respiratory Tract Neoplasms | 10 |
| Bronchial Neoplasms | 9 |
| Neoplasms | 9 |
| Thoracic Neoplasms | 9 |
| Carcinoma | 7 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.